Spectrum Brands (SPB) Q3 2024 earnings summary

Executive summary

• Net sales grew 6.0% year-over-year to $779.4 million, with organic sales up 7.1%, driven by volume increases, strong e-commerce momentum, and favorable weather, with all business units contributing.

• Adjusted EBITDA reached $106.3 million, up 7.9%, despite increased brand and innovation investments, and net income from continuing operations was $19.1 million, reversing a prior year loss.

• Gross margin improved by 310 basis points to 38.9%, reflecting operational efficiencies, lower inventory costs, and improved product mix.

• The company continued to deleverage, retiring $1.174 billion in bonds, issuing $350 million in convertible/exchangeable securities, and reducing net debt to approximately $272 million.

• Share repurchases reduced the share count by 32% since the HHI transaction, with $400 million to $500 million remaining authorized and $142 million repurchased in Q3.

Financial highlights

• Q3 FY24 net sales were $779.4 million, up from $735.5 million in Q3 FY23, with gross profit rising 14.9% to $302.8 million and operating income at $47.7 million, reversing a prior year loss.

• Adjusted diluted EPS rose to $1.10, aided by higher EBITDA and a lower share count.

• Interest expense dropped by $14.6 million year-over-year to $15.7 million, reflecting lower debt.

• Net debt at quarter-end was approximately $272 million, with total liquidity near $800 million and cash and short-term investments at $307 million.

• Dividend per share was maintained at $0.42 for the quarter.

Outlook and guidance

• Fiscal 2024 net sales are expected to be flat year-over-year, but adjusted EBITDA (excluding investment income) is projected to grow about 20%.

• Guidance assumes continued favorable weather, strong e-commerce, and sales recovery in key categories, with a cautious outlook for fiscal 2025 due to macroeconomic and geopolitical uncertainties.

• Management expects continued margin improvement from cost actions, SKU rationalization, and lower input costs.

• Long-term net leverage ratio target remains 2.0–2.5x.

• The company is progressing with the planned separation of the Home and Personal Care (HPC) segment, with timing and benefits subject to market and regulatory conditions.